Found: 4
Select item for more details and to access through your institution.
An updated systematic review and meta-analysis on efficacy of Sofosbuvir in treating hepatitis C-infected patients with advanced chronic kidney disease.
- Published in:
- PLoS ONE, 2021, v. 16, n. 2, p. 1, doi. 10.1371/journal.pone.0246594
- By:
- Publication type:
- Article
Synthesis of Depo-Medrol-chitosan hydrogel as new drug slow-release appliance and investigation of release kinetics by high-performance liquid chromatography.
- Published in:
- Biomedical Chromatography, 2016, v. 30, n. 9, p. 1346, doi. 10.1002/bmc.3679
- By:
- Publication type:
- Article
A Quick and Sensitive LC-MS/MS Method for Simultaneous Quantification of Sofosbuvir Metabolite (GS-331007) in Human Plasma: Application to Hepatitis C Infected Patients with End-Stage Renal Disease.
- Published in:
- Middle East Journal of Digestive Diseases, 2024, v. 16, n. 2, p. 96, doi. 10.34172/mejdd.2024.375
- By:
- Publication type:
- Article
The combination of sofosbuvir and daclatasvir is effective and safe in treating patients with hepatitis C and severe renal impairment.
- Published in:
- Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 9, p. 1590, doi. 10.1111/jgh.14994
- By:
- Publication type:
- Article